Find uplifting stories about heroes, innovations, and solutions
17 results for "shinya yamanaka"
A Japanese scientist discovered how to transform ordinary adult cells into stem cells, eliminating the need for controversial embryonic tissue. His Nobel Prize-winning work is now helping patients with Parkinson's and other diseases get treatments using their own cells. #
Japan just became the first country to approve stem cell therapy for Parkinson's disease, offering hope to 10 million patients worldwide. The groundbreaking treatment will be available to patients this summer.
Japan just greenlit insurance coverage for a groundbreaking Parkinson's treatment that uses stem cells to replace damaged brain cells. It's the first time regenerative medicine using iPS cells will be available to patients anywhere in the world.
Japan just approved the first-ever stem cell therapy that can repair hearts damaged by severe heart failure. This groundbreaking treatment could offer hope to millions of people worldwide living with life-threatening heart conditions.
A groundbreaking treatment that makes old cells young again is moving to human trials this year, starting with restoring vision in glaucoma patients. After years of successful tests in mice, this breakthrough could one day rejuvenate aging organs throughout the body.
Patients with Parkinson's disease and severe heart failure will soon receive groundbreaking stem cell therapies in Japan, marking the first time these treatments become commercially available anywhere in the world. The breakthrough could reach patients as early as this summer.
A Boston patient just received the world's first cellular reprogramming injection designed to reverse aging in the human body. The groundbreaking trial could transform how we treat age-related diseases.
Japan just approved the first commercially available stem cell treatments for Parkinson's disease and heart failure, bringing hope to millions worldwide. Patients could receive these groundbreaking therapies as early as this summer.
Scientists at Duke University used stem cells to grow specialized retinal blood vessel cells that restored vision in blind mice. The breakthrough could lead to affordable treatments for millions facing vision loss from diseases like diabetic retinopathy.
Japan just greenlit two groundbreaking stem cell treatments that could restore hope for people with Parkinson's disease and severe heart failure. These are the first therapies of their kind available anywhere in the world.
After years of success in mice, researchers are launching the first human trial of a cellular therapy that could turn back the clock on aging tissues and organs. The groundbreaking test could reshape how we think about getting older.
Japan just greenlit the world's first commercially available stem cell treatment for Parkinson's disease, potentially reaching patients this summer. The breakthrough could bring hope to 10 million people worldwide living with the degenerative disorder.
Yokohama's mayor resigned after calling staff "human trash" and telling officials to commit ritual suicide, signaling a major shift in Japan's workplace culture. Voters are finally saying no to abusive leadership.
Toyota has built a real-life testing town near Mount Fuji where 100 residents already live alongside delivery robots, autonomous vehicles, and AI systems. The experimental city helps gather real-world data on human-machine interaction that could shape safer technology worldwide.
Patients with severe heart failure in Japan can now access a revolutionary treatment that uses lab-grown heart cells to repair damaged hearts. The breakthrough therapy is only the second stem cell product covered by public insurance in the country.
A Boston startup just received FDA approval to test a groundbreaking age reversal treatment in humans for the first time. The therapy could restore vision in glaucoma patients by resetting cells to a younger, healthier state.
Japan is deploying AI-powered robots to fill essential jobs as its workforce shrinks by millions. Rather than replacing workers, the technology is keeping factories, warehouses, and critical services running.